;PMID: 10320758
;source_file_3007.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..53] = [t:0..53]
;1)sentence:[e:59..193] = [t:59..193]
;2)section:[e:197..225] = [t:197..225]
;3)section:[e:229..345] = [t:229..345]
;4)sentence:[e:349..492] = [t:349..492]
;5)sentence:[e:493..638] = [t:493..638]
;6)sentence:[e:639..831] = [t:639..831]
;7)sentence:[e:832..956] = [t:832..956]
;8)sentence:[e:957..1136] = [t:957..1136]
;9)sentence:[e:1137..1271] = [t:1137..1271]
;10)sentence:[e:1272..1404] = [t:1272..1404]
;11)sentence:[e:1405..1496] = [t:1405..1496]
;12)section:[e:1498..1534] = [t:1498..1534]
;13)section:[e:1538..1583] = [t:1538..1583]

;section 0 Span:0..53
;Brain Res Dev Brain Res.  1999 May 14;114(2):193-200.
(SEC
  (FRAG (NNP:[0..5] Brain) (NNP:[6..9] Res) (NNP:[10..13] Dev)
        (NNP:[14..19] Brain) (NNP:[20..23] Res) (IN:[23..24] .)
        (CD:[26..30] 1999) (NNP:[31..34] May) (CD:[35..42] 14;114-LRB-)
        (CD:[42..43] 2) (-RRB-:[43..44] -RRB-) (CD:[44..48] :193)
        (CD:[48..52] -200) (.:[52..53] .)))

;sentence 1 Span:59..193
;Suppression of an actin-binding protein, drebrin, by antisense transfection 
;attenuates neurite outgrowth in neuroblastoma B104 cells.
;[77..98]:gene-protein:"actin-binding protein"
;[100..107]:gene-protein:"drebrin"
;[168..181]:malignancy-type:"neuroblastoma"
(SENT
  (S-HLN
    (NP-SBJ
      (NP (NN:[59..70] Suppression))
      (PP (IN:[71..73] of)
        (NP
          (NP (DT:[74..76] an)
            
            (ADJP (NN:[77..82] actin) (HYPH:[82..83] -) (VBG:[83..90] binding))
            (NN:[91..98] protein))
          (,:[98..99] ,)
          (NP (NN:[100..107] drebrin))))
      (,:[107..108] ,)
      (PP (IN:[109..111] by)
        (NP (JJ:[112..121] antisense) (NN:[122..134] transfection))))
    (VP (VBZ:[136..146] attenuates)
      (NP (NN:[147..154] neurite) (NN:[155..164] outgrowth))
      (PP-LOC (IN:[165..167] in)
        (NP (NN:[168..181] neuroblastoma) (NN:[182..186] B104)
            (NNS:[187..192] cells))))
    (.:[192..193] .)))

;section 2 Span:197..225
;Toda M, Shirao T, Uyemura K.
(SEC
  (FRAG (NNP:[197..201] Toda) (NNP:[202..204] M,) (NNP:[205..211] Shirao)
        (NNP:[212..213] T) (,:[213..214] ,) (NNP:[215..222] Uyemura)
        (NNP:[223..225] K.)))

;section 3 Span:229..345
;Department of Physiology, Keio University School of Medicine, 35
;Shinanomachi,  Shinjuku-ku, Tokyo, 160-8582, Japan.
(SEC
  (FRAG (NNP:[229..239] Department) (IN:[240..242] of)
        (NNP:[243..253] Physiology) (,:[253..254] ,) (NNP:[255..259] Keio)
        (NNP:[260..270] University) (NNP:[271..277] School) (IN:[278..280] of)
        (NNP:[281..289] Medicine) (,:[289..290] ,) (CD:[291..293] 35)
        (NNP:[294..306] Shinanomachi) (,:[306..307] ,)
        (NNP:[309..320] Shinjuku-ku) (,:[320..321] ,) (NNP:[322..327] Tokyo)
        (,:[327..328] ,) (CD:[329..332] 160) (HYPH:[332..333] -)
        (CD:[333..337] 8582) (,:[337..338] ,) (NNP:[339..344] Japan)
        (.:[344..345] .)))

;sentence 4 Span:349..492
;Drebrins, actin-binding proteins, are dominantly expressed during
;embryogenesis  and accumulated in neurite processes of postmigratory
;neurons.
;[349..357]:gene-protein:"Drebrins"
;[359..381]:gene-protein:"actin-binding proteins"
(SENT
  (S
    (NP-SBJ-1
      (NP (NNS:[349..357] Drebrins))
      (,:[357..358] ,)
      (NP
        (ADJP (NN:[359..364] actin) (HYPH:[364..365] -) (VBG:[365..372] binding))
        (NNS:[373..381] proteins)))
    (,:[381..382] ,)
    (VP (VBP:[383..386] are)
      (VP
        (VP
          (ADVP (RB:[387..397] dominantly))
          (VBN:[398..407] expressed)
          (NP-1 (-NONE-:[407..407] *))
          (PP-TMP (IN:[408..414] during)
            (NP (NN:[415..428] embryogenesis))))
        (CC:[430..433] and)
        (VP (VBN:[434..445] accumulated)
          (NP-1 (-NONE-:[445..445] *))
          (PP (IN:[446..448] in)
            (NP
              (NP (NN:[449..456] neurite) (NNS:[457..466] processes))
              (PP (IN:[467..469] of)
                (NP (JJ:[470..483] postmigratory) (NNS:[484..491] neurons))))))))
    (.:[491..492] .)))

;sentence 5 Span:493..638
;While the  cytoskeletal proteins are the important factors for regulating
;neurite  outgrowth, the cellular mechanism in neurons is still unclear.
;[504..525]:gene-protein:"cytoskeletal proteins"
(SENT
  (S
    (SBAR-ADV (IN:[493..498] While)
      (S
        (NP-SBJ (DT:[499..502] the)
           (JJ:[504..516] cytoskeletal) (NNS:[517..525] proteins))
        (VP (VBP:[526..529] are)
          (NP-PRD
            (NP (DT:[530..533] the) (JJ:[534..543] important)
                (NNS:[544..551] factors))
            (PP (IN:[552..555] for)
              (S-NOM
                (NP-SBJ (-NONE-:[555..555] *))
                (VP (VBG:[556..566] regulating)
                  (NP (NN:[567..574] neurite) (NN:[576..585] outgrowth)))))))))
    (,:[585..586] ,)
    (NP-SBJ
      (NP (DT:[587..590] the) (JJ:[591..599] cellular) (NN:[600..609] mechanism))
      (PP-LOC (IN:[610..612] in)
        (NP (NNS:[613..620] neurons))))
    (VP (VBZ:[621..623] is)
      (ADVP-TMP (RB:[624..629] still))
      (ADJP-PRD (JJ:[630..637] unclear)))
    (.:[637..638] .)))

;sentence 6 Span:639..831
;To address the  role of drebrins in the neurite outgrowth, we have studied
;the effect of  suppression of drebrin on a rat neuroblastoma B104 cell line,
;which  constitutively expresses drebrin.
;[663..671]:gene-protein:"drebrins"
;[744..751]:gene-protein:"drebrin"
;[761..774]:malignancy-type:"neuroblastoma"
;[823..830]:gene-protein:"drebrin"
(SENT
  (S
    (S-PRP
      (NP-SBJ (-NONE-:[639..639] *))
      (VP (TO:[639..641] To)
        (VP (VB:[642..649] address)
          (NP
            (NP (DT:[650..653] the) (NN:[655..659] role))
            (PP (IN:[660..662] of)
              (NP (NNS:[663..671] drebrins))))
          (PP (IN:[672..674] in)
            (NP (DT:[675..678] the) (NN:[679..686] neurite)
                (NN:[687..696] outgrowth))))))
    (,:[696..697] ,)
    (NP-SBJ (PRP:[698..700] we))
    (VP (VBP:[701..705] have)
      (VP (VBN:[706..713] studied)
        (NP
          (NP (DT:[714..717] the) (NN:[718..724] effect))
          (PP (IN:[725..727] of)
            (NP
              (NP (NN:[729..740] suppression))
              (PP (IN:[741..743] of)
                (NP (NN:[744..751] drebrin)))))
          (PP (IN:[752..754] on)
            (NP
              (NP (DT:[755..756] a) (NN:[757..760] rat)
                  (NN:[761..774] neuroblastoma) (NN:[775..779] B104)
                  (NN:[780..784] cell) (NN:[785..789] line))
              (,:[789..790] ,)
              (SBAR
                (WHNP-1 (WDT:[791..796] which))
                (S
                  (NP-SBJ-1 (-NONE-:[796..796] *T*))
                  (ADVP (RB:[798..812] constitutively))
                  (VP (VBZ:[813..822] expresses)
                    (NP (NN:[823..830] drebrin))))))))))
    (.:[830..831] .)))

;sentence 7 Span:832..956
;Deprivation of serum or addition of  gangliosides in the culture medium
;induced remarkable neurite outgrowth of B104  cells.
(SENT
  (S
    (NP-SBJ
      (NP
        (NP (NN:[832..843] Deprivation))
        (PP (IN:[844..846] of)
          (NP (NN:[847..852] serum))))
      (CC:[853..855] or)
      (NP
        (NP (NN:[856..864] addition))
        (PP (IN:[865..867] of)
          (NP (NNS:[869..881] gangliosides)))
        (PP-LOC (IN:[882..884] in)
          (NP (DT:[885..888] the) (NN:[889..896] culture) (NN:[897..903] medium)))))
    (VP (VBD:[904..911] induced)
      (NP
        (NP (JJ:[912..922] remarkable) (NN:[923..930] neurite)
            (NN:[931..940] outgrowth))
        (PP (IN:[941..943] of)
          (NP (NN:[944..948] B104) (NNS:[950..955] cells)))))
    (.:[955..956] .)))

;sentence 8 Span:957..1136
;We transfected B104 cells with an antisense construct of human drebrin E 
;cDNA and found that the drebrin expression was significantly reduced in the 
;stable antisense cell lines.
;[1020..1029]:gene-rna:"drebrin E"
;[1055..1062]:gene-protein:"drebrin"
(SENT
  (S
    (NP-SBJ (PRP:[957..959] We))
    (VP
      (VP (VBD:[960..971] transfected)
        (NP (NN:[972..976] B104) (NNS:[977..982] cells))
        (PP (IN:[983..987] with)
          (NP
            (NP (DT:[988..990] an) (JJ:[991..1000] antisense)
                (NN:[1001..1010] construct))
            (PP (IN:[1011..1013] of)
              (NP (JJ:[1014..1019] human)
                (NML (NN:[1020..1027] drebrin) (NN:[1028..1029] E))
                (NN:[1031..1035] cDNA))))))
      (CC:[1036..1039] and)
      (VP (VBD:[1040..1045] found)
        (SBAR (IN:[1046..1050] that)
          (S
            (NP-SBJ-1 (DT:[1051..1054] the) (NN:[1055..1062] drebrin)
                      (NN:[1063..1073] expression))
            (VP (VBD:[1074..1077] was)
              (ADVP (RB:[1078..1091] significantly))
              (VP (VBN:[1092..1099] reduced)
                (NP-1 (-NONE-:[1099..1099] *))
                (PP (IN:[1100..1102] in)
                  (NP (DT:[1103..1106] the) (JJ:[1108..1114] stable)
                      (JJ:[1115..1124] antisense) (NN:[1125..1129] cell)
                      (NNS:[1130..1135] lines)))))))))
    (.:[1135..1136] .)))

;sentence 9 Span:1137..1271
;In response to serum deprivation and gangliosides  treatment, their ability
;to extend neurite processes was significantly  attenuated.
(SENT
  (S
    (PP (IN:[1137..1139] In)
      (NP
        (NP (NN:[1140..1148] response))
        (PP (TO:[1149..1151] to)
          (NP
            (NP (NN:[1152..1157] serum) (NN:[1158..1169] deprivation))
            (CC:[1170..1173] and)
            (NP (NNS:[1174..1186] gangliosides) (NN:[1188..1197] treatment))))))
    (,:[1197..1198] ,)
    (NP-SBJ-1 (PRP$:[1199..1204] their) (NN:[1205..1212] ability)
      (S
        (NP-SBJ (-NONE-:[1212..1212] *))
        (VP (TO:[1213..1215] to)
          (VP (VB:[1216..1222] extend)
            (NP (NN:[1223..1230] neurite) (NNS:[1231..1240] processes))))))
    (VP (VBD:[1241..1244] was)
      (ADVP (RB:[1245..1258] significantly))
      (VP (VBN:[1260..1270] attenuated)
        (NP-1 (-NONE-:[1270..1270] *))))
    (.:[1270..1271] .)))

;sentence 10 Span:1272..1404
;In contrast, the cell proliferation of the antisense transfectants  was
;arrested by serum deprivation similar to control B104 cells.
(SENT
  (S
    (PP (IN:[1272..1274] In)
      (NP (NN:[1275..1283] contrast)))
    (,:[1283..1284] ,)
    (NP-SBJ-1
      (NP (DT:[1285..1288] the) (NN:[1289..1293] cell)
          (NN:[1294..1307] proliferation))
      (PP (IN:[1308..1310] of)
        (NP (DT:[1311..1314] the) (JJ:[1315..1324] antisense)
            (NNS:[1325..1338] transfectants))))
    (VP (VBD:[1340..1343] was)
      (VP (VBN:[1344..1352] arrested)
        (NP-1 (-NONE-:[1352..1352] *))
        (PP (IN:[1353..1355] by)
          (NP-LGS
            (NP (NN:[1356..1361] serum) (NN:[1362..1373] deprivation))
            (ADJP (JJ:[1374..1381] similar)
              (PP (TO:[1382..1384] to)
                (NP (NN:[1385..1392] control) (NN:[1393..1397] B104)
                    (NNS:[1398..1403] cells))))))))
    (.:[1403..1404] .)))

;sentence 11 Span:1405..1496
;These data  suggest that the drebrins are required for neurite outgrowth in
;neuronal cells.
;[1434..1442]:gene-protein:"drebrins"
(SENT
  (S
    (NP-SBJ (DT:[1405..1410] These) (NNS:[1411..1415] data))
    (VP (VBP:[1417..1424] suggest)
      (SBAR (IN:[1425..1429] that)
        (S
          (NP-SBJ-1 (DT:[1430..1433] the) (NNS:[1434..1442] drebrins))
          (VP (VBP:[1443..1446] are)
            (VP (VBN:[1447..1455] required)
              (NP-1 (-NONE-:[1455..1455] *))
              (PP (IN:[1456..1459] for)
                (NP (NN:[1460..1467] neurite) (NN:[1468..1477] outgrowth)))
              (PP-LOC (IN:[1478..1480] in)
                (NP (JJ:[1481..1489] neuronal) (NNS:[1490..1495] cells))))))))
    (.:[1495..1496] .)))

;section 12 Span:1498..1534
;Copyright 1999 Elsevier Science B.V.
(SEC
  (FRAG (NN:[1498..1507] Copyright) (CD:[1508..1512] 1999)
        (NNP:[1513..1521] Elsevier) (NNP:[1522..1529] Science)
        (NNP:[1530..1533] B.V) (.:[1533..1534] .)))

;section 13 Span:1538..1583
;PMID: 10320758 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1538..1542] PMID) (::[1542..1543] :) (CD:[1544..1552] 10320758)
        (NN:[1553..1554] -LSB-) (NNP:[1554..1560] PubMed) (::[1561..1562] -)
        (NN:[1563..1570] indexed) (IN:[1571..1574] for)
        (NNP:[1575..1583] MEDLINE-RSB-)))
